Hillstream Biopharma Shares Owned By Insiders vs. EBITDA

HILSDelisted Stock  USD 0.39  0.01  2.50%   
Based on the key profitability measurements obtained from Hillstream Biopharma's financial statements, Hillstream Biopharma may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Hillstream Biopharma's ability to earn profits and add value for shareholders.
For Hillstream Biopharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hillstream Biopharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hillstream Biopharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hillstream Biopharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hillstream Biopharma over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Please note, there is a significant difference between Hillstream Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hillstream Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hillstream Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Hillstream Biopharma EBITDA vs. Shares Owned By Insiders Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Hillstream Biopharma's current stock value. Our valuation model uses many indicators to compare Hillstream Biopharma value to that of its competitors to determine the firm's financial worth.
Hillstream Biopharma is rated # 2 in shares owned by insiders category among its peers. It is rated # 4 in ebitda category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Hillstream Biopharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Hillstream EBITDA vs. Shares Owned By Insiders

Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Hillstream Biopharma

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
38.90 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

Hillstream Biopharma

EBITDA

 = 

Revenue

-

Basic Expenses

 = 
(6.88 M)
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Hillstream EBITDA Comparison

Hillstream Biopharma is currently under evaluation in ebitda category among its peers.

Hillstream Biopharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Hillstream Biopharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Hillstream Biopharma will eventually generate negative long term returns. The profitability progress is the general direction of Hillstream Biopharma's change in net profit over the period of time. It can combine multiple indicators of Hillstream Biopharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death for the treatment resistant cancers. The company was incorporated in 2017 and is based in Bridgewater, New Jersey. Hillstream Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.

Hillstream Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Hillstream Biopharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Hillstream Biopharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Hillstream Biopharma's important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Hillstream Biopharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Exposure Probability Now

   

Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module

Use Investing Themes to Complement your Hillstream Biopharma position

In addition to having Hillstream Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Printing and Publishing Thematic Idea Now

Printing and Publishing
Printing and Publishing Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Printing and Publishing theme has 21 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Printing and Publishing Theme or any other thematic opportunities.
View All  Next Launch
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Hillstream Stock

If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies